Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 801–900 of 1,016
Sundar, D., Yu, Y., Katiyar, S. P., Putri, J. F., Dhanjal, J. K., Wang, J., Sari, A. N., Kolettas, E., Kaul, S. C., & Wadhwa, R. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1099-x · Cited by 51
Self-citationA tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Liu, C., Li, H., Wang, K., Zhuang, J., Chu, F., Gao, C., Liu, L., Feng, F., Zhou, C., Zhang, W., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00368 · Cited by 49
“Its deranged expression is not only a reflection of increased proliferation but also a necessary condition for initiating DNA replication as a potential “driving force” (51, 52).”
BackgroundSmall Molecule CDK Inhibitors for the Therapeutic Management of Cancer
Goel, B., Tripathi, N., Bhardwaj, N., & Jain, S. K. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200516152756 · Cited by 48
Mouse embryonic fibroblasts null for the Krüppel-like factor 4 gene are genetically unstable
Hagos, E. G., Ghaleb, A. M., Dalton, W. B., Bialkowska, A. B., & Yang, V. W. (2009) · Oncogene · doi:10.1038/onc.2008.465 · Cited by 51
“Alternatively, overexpression of cyclin E has been shown to lead to the formation of double-stranded DNA breaks because of replication fork collapse (Bartkova et al., 2006).”
BackgroundTherapy-induced senescent tumor cells in cancer relapse
Song, K., Wang, J., & Huang, D. (2023) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2023.09.001 · Cited by 57
“34 Cellular senescence markers SA-𝛽 -Gal and/or p16 INK4a expressing cells have been observed in certain neoplastic tissues of patients, including neurofibroma, 35 colon adenoma, 36 and lymphoma.”
BackgroundDeregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
CLCA2 as a p53-Inducible Senescence Mediator
Tanikawa, C., Nakagawa, H., Furukawa, Y., Nakamura, Y., & Matsuda, K. (2012) · Neoplasia · doi:10.1593/neo.111700 · Cited by 48
“Because cellular senescence was observed in precancerous tissues [27,28], senescence is likely to function as a barrier for malignant transformation in the carcinogenesis process [29].”
BackgroundSelf-citationTGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence
Kretová, M., Sabová, L., Hodný, Z., Bártek, J., Kollárovič, G., Nelson, B. D., Hubáčková, S., & Luciaková, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.029 · Cited by 46
Noda, A., Hirai, Y., Hamasaki, K., Mitani, H., Nakamura, N., & Kodama, Y. (2012) · Journal of Cell Science · doi:10.1242/jcs.101006 · Cited by 55
“…senescence, the expression of an activated RAS or BRAF in non-tumour cells results in enforced multiple rounds of replicon firing during S phase, and thereby, produces excess DSBs, which eventually causes cells to undergo premature senescence (DiMicco et al., 2006; Bartkova et al., 2006).”
BackgroundChemoprevention of Prostate Cancer: Soy Isoflavones and Curcumin
Horie, S. (2012) · Korean journal of urology · doi:10.4111/kju.2012.53.10.665 · Cited by 49
“Markers of double-strand breaks, such as nuclear γH2AX foci (a histone phosphorylation event that occurs on chromatin surrounding a double-strand break), are markedly elevated in some precancerous lesions [80,81].”
BackgroundTalhaoui, I., Matkarimov, B. T., Tchénio, T., Zharkov, D. O., & Saparbaev, M. K. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.040 · Cited by 47
Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication
Singh, S., Vaughan, C. A., Frum, R. A., Grossman, S. R., Deb, S., & Deb, S. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87724 · Cited by 50
La prévention du cancer et la relation dose–effet : l’effet cancérogène des rayonnements ionisants
Tubiana, M. (2009) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2009.03.003 · Cited by 57
Cheng, K., Grisendi, S., Clohessy, J. G., Majid, S. M., Bernardi, R., Sportoletti, P., & Pandolfi, P. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210549 · Cited by 48
The many facets of the Tim-Tipin protein families’ roles in chromosome biology
McFarlane, R. J., Mian, S., & Dalgaard, J. Z. (2010) · Cell Cycle · doi:10.4161/cc.9.4.10676 · Cited by 47
Conserved RB functions in development and tumor suppression
Gordon, G. M., & Du, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1117-z · Cited by 53
“Indeed, the DNA damage response to aberrant replication is known to be critical for inducing senescence upon oncogene activation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundDNA Replication Stress and Cancer: Cause or Cure?
Taylor, E. M., & Lindsay, H. D. (2015) · Future Oncology · doi:10.2217/fon.15.292 · Cited by 49
A role for the spindle assembly checkpoint in the DNA damage response
Palou, R., Palou, G., & Quintana, D. G. (2016) · Current Genetics · doi:10.1007/s00294-016-0634-y · Cited by 48
Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
Dahl, E. S., & Aird, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00291 · Cited by 47
“One of the underlying mechanisms of OIS is increased replication stress, leading to DNA damage accumulation and cell cycle arrest (63, 64).”
BackgroundWu, X., Kabalane, H., Kahli, M., Petryk, N., Laperrousaz, B., Jaszczyszyn, Y., Drillon, G., Nicolini, F., Pérot, G., Robert, A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky797 · Cited by 56
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Sanjiv, K., Hagenkort, A., Calderón‐Montaño, J. M., Koolmeister, T., Reaper, P. M., Mortusewicz, O., Jacques, S. A., Kuiper, R., Schultz, N., Scobie, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.12.031 · Cited by 49
Self-citationSenescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 52
Wolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E., & Neil, J. C. (2009) · Oncogene · doi:10.1038/onc.2009.101 · Cited by 44
The Mre11 Complex Suppresses Oncogene-Driven Breast Tumorigenesis and Metastasis
Gupta, G. P., Vanness, K., Barlas, A., Manova-Todorova, K. O., Wen, Y. H., & Petrini, J. H. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.001 · Cited by 48
Suppression of Apoptosis by PIF1 Helicase in Human Tumor Cells
Gagou, M. E., Ganesh, A. N., Thompson, R. H., Phear, G. A., Sanders, C. M., & Meuth, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4404 · Cited by 49
“It has been reported that oncogene activation and the loss of control of entry into Sphase may lead to chronic DNA replication stress in many types of tumor cells (29, 30).”
BackgroundNodin, B., Zendehrokh, N., Sundström, M., & Jirström, K. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-106 · Cited by 46
“DNA hyperreplication as a consequence of hyperproliferative oncogenic stimuli exposes the cell to replication stress [46] and triggers the activation of the checkpoint response [47,48].”
p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase
Zemskova, M., Lilly, M. B., Lin, Y.-W., Song, J. H., & Kraft, A. S. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0174 · Cited by 49
“In precancerous lesions in animals and humans OIS is a part of a tumorigenesis barrier imposed by DNA damage checkpoints (34).”
InfluentialLarge cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion
Ikeda, H., Sasaki, M., Sato, Y., Harada, K., Zen, Y., Mitsui, T., & Nakanuma, Y. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.009 · Cited by 44
“Senescence is reported to act as a safeguard against malignant transformation [6-9,30].”
BackgroundInfluentialBarbouti, A., Evangelou, K., Pateras, I. S., Papoudou-Bai, A., Patereli, A., Stefanaki, K., Rontogianni, D., Muñoz-Espín, D., Kanavaros, P., & Gorgoulis, V. G. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.02.005 · Cited by 44
Self-citationFinn, K. J., & Li, J. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003192 · Cited by 40
Preserving the genome by regulating chromatin association with the nuclear envelope
Bermejo, R., Kumar, A., & Foiani, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.05.007 · Cited by 49
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
Xue, L., Nolla, H., Suzuki, A., Mak, T. W., & Winoto, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712059105 · Cited by 44
“Oncogene-induced senescence is thought to be part of the ATM DNA damage pathway that involves many proteins, including phosphorylation/activation of p53, chk1, chk2, -H2AX, and ATM (19, 24).”
BackgroundHe, Y., Pasupala, N., Zhi, H., Dorjbal, B., Hussain, I., Shih, H., Bhattacharyya, S., Biswas, R., Miljković, M. D., Semmes, O. J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005568118 · Cited by 44
Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress
Gagou, M. E., Ganesh, A. N., Phear, G. A., Robinson, D. A., Petermann, E., Cox, A., & Meuth, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2501 · Cited by 44
CARF Is a Vital Dual Regulator of Cellular Senescence and Apoptosis
Hasan, M. K., Cheung, C., Kaul, Z., Shah, N., Sakaushi, S., Sugimoto, K., Oka, S., Kaul, S. C., & Wadhwa, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805778200 · Cited by 48
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171207 · Cited by 43
“The DNA damage response (DDR) pathway is a central regulator of OIS (Bartkova et al., 2006; Bartek et al., 2007; Mallette et al., 2007; Courtois-Cox et al., 2008).”
BackgroundInfluentialOncogene‐induced cellular senescence elicits an anti‐ Warburg effect
Li, M., Durbin, K. R., Sweet, S. M. M., Tipton, J. D., Zheng, Y., & Kelleher, N. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201200298 · Cited by 43
“It has recently been observed that oncogene-induced senescence (OIS) is associated with activation of the DNA damage response [6,10].”
BackgroundMajera, D., Skrott, Z., Chroma, K., Merchut-Maya, J. M., Mistrik, M., & Bartek, J. (2020) · Cells · doi:10.3390/cells9020469 · Cited by 43
Igarashi, T., Mazevet, M., Yasuhara, T., Yano, K., Mochizuki, A., Nishino, M., Yoshida, T., Yoshida, Y., Takamatsu, N., Yoshimi, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40578-2 · Cited by 46
“Activated oncogenes cause RS and DNA damage in cultured cells, thereby triggering the DNA damage response (DDR) and cell cycle checkpoints that provide a biological anticancer barrier in the early stages of tumorigenesis 65,66 .”
Comprehensive genomic characterization of early-stage bladder cancer
Prip, F., Lamy, P., Lindskrog, S. V., Strandgaard, T., Nordentoft, I., Birkenkamp‐Demtröder, K., Birkbak, N. J., Kristjánsdóttir, N., Kjær, A., Andreasen, T. G., et al. (2025) · Nature Genetics · doi:10.1038/s41588-024-02030-z · Cited by 46
“7a), possibly reflecting a response to the cell stress (including DNA damage) induced by the impaired cell cycle regulation 25 .”
Nussinov, R., Tsai, C.-J., Muratcioglu, S., Jang, H., Gursoy, A., & Keskin, O. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1100079 · Cited by 42
Understanding specific functions of PARP-2: new lessons for cancer therapy.
Ali, S. O., Khan, F. A., Galindo-Campos, M. A., & Yélamos, J. (2016) · RECERCAT (Consorci de Serveis Universitaris de Catalunya) · Cited by 61
BLM prevents instability of structure-forming DNA sequences at common fragile sites
Wang, H., Li, S., Zhang, H., Wang, Y., Hao, S., & Wu, X. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007816 · Cited by 43
Resveratrol and its Related Polyphenols Contribute to the Maintenance of Genome Stability
Matsuno, Y., Atsumi, Y., Alauddin, M., Rana, M. M., Fujimori, H., Hyodo, M., Shimizu, A., Ikuta, T., Tani, H., Torigoe, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62292-5 · Cited by 49
Senescence and Host–Pathogen Interactions
Humphreys, D., ElGhazaly, M., & Frisan, T. (2020) · Cells · doi:10.3390/cells9071747 · Cited by 46
“Conversely, OIS is the consequence of the sustained replication promoted by oncogene overexpression, which leads to the collapse of the replication forks, the induction of DNA damage and DDR activation, a phenomenon considered a powerful barrier for cancer development [29].”
BackgroundMognato, M., Burdak‐Rothkamm, S., & Rothkamm, K. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108346 · Cited by 47
Frediani, E., Scavone, F., Laurenzana, A., Chillà, A., Tortora, K., Cimmino, I., Leri, M., Bucciantini, M., Mangoni, M., Fibbi, G., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17255 · Cited by 44
The Viral Oncoprotein Tax Sequesters DNA Damage Response Factors by Tethering MDC1 to Chromatin
Belgnaoui, S. M., Fryrear, K. A., Nyalwidhe, J. O., Guo, X., & Semmes, O. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146373 · Cited by 44
Huo, D., Chen, H., Cheng, Y., Song, X., Zhang, K., Li, M. J., & Xuan, C. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0397-3 · Cited by 42
Chromosomal Instability in Genome Evolution: From Cancer to Macroevolution
Comaills, V., & Castellano‐Pozo, M. (2023) · Biology · doi:10.3390/biology12050671 · Cited by 46
“However, low levels of replication stress can bypass these sensors and continue with cell proliferation [111], even promoting unusual mitotic DNA synthesis (MiDAS) to promote replication in these lagging regions before the completion of mitosis [108,112].”
BackgroundSenataxin and R-loops homeostasis: multifaced implications in carcinogenesis
Gatti, V., Domenico, S. D., Melino, G., & Peschiaroli, A. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01441-x · Cited by 43
Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest
Nikitin, P. A., Price, A. M., McFadden, K., Yan, C. M., & Luftig, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087299 · Cited by 43
Regulation and roles of Cdc7 kinase under replication stress
Yamada, M., Masai, H., & Bártek, J. (2014) · Cell Cycle · doi:10.4161/cc.29251 · Cited by 50
“Such DDK/ RAD18-antagonizing drugs could be used as single treatment in subsets of patients selected based on suitable biomarker information on the DNA repair pathway status and extent of replication stress.(67,70,81,96,97) Alternatively, they could be combined with standard-of-care genotoxic chemotherapeutics or ioni…”
BackgroundMethodOncogenic events associated with endometrial and ovarian cancers are rare in endometriosis
Vestergaard, A. L., Thorup, K., Knudsen, U. B., Munk, T., Rosbach, H., Poulsen, J. B., Guldberg, P., & Martensen, P. M. (2011) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gar049 · Cited by 39
“Although the mechanism of oncogene-induced senescence is not fully understood, it may be due to unbalanced DNA replication that initiates a classic DNA-damage response (Bartkova et al., 2006).”
BackgroundAtaxia telangiectasia syndrome: moonlighting ATM
Zaki‐Dizaji, M., Akrami, S. M., Abolhassani, H., Rezaei, N., & Aghamohammadi, A. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1392856 · Cited by 44
“[172,173], causing the cells gain a potential for neoplastic transformation that decreases tumor latency and/or increases”
BackgroundSelf-citationHydrogen sulfide in longevity and pathologies: Inconsistency is malodorous
Sokolov, A. S., Nekrasov, P. V., Shaposhnikov, M. V., & Moskalev, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101262 · Cited by 45
Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis
Lantuéjoul, S., Raynaud, C. M., Salameire, D., Gazzéri, S., Moro‐Sibilot, D., Soria, J., Brambilla, C., & Brambilla, E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0142 · Cited by 47
Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ
Brondello, J., Pillaire, M., Rodriguez, C., Gourraud, P., Sèlves, J., Cazaux, C., & Piette, J. (2008) · Oncogene · doi:10.1038/onc.2008.212 · Cited by 46
“Clinical observations have shown that at early stages of human tumorigenesis, cells are characterized by genome instability and DDR deficiency (Gorgoulis et al., 2005; Bartkova et al., 2006; Bartek et al., 2007).”
BackgroundResultInfluentialDNA damage response(DDR): a link between cellular senescence and human cytomegalovirus
Wu, X., Zhou, X., Wang, S., & Mao, G. (2023) · Virology Journal · doi:10.1186/s12985-023-02203-y · Cited by 49
“Oncogene-induced senescence (OIS) is characterized by substantial activation of the DDR pathway and the formation of DDR foci in senescent cells (also known as senescence-associated DNA-damage foci; SDFs) [7, 67, 72, 73].”
BackgroundTripathi, K. K., Mani, C., Barnett, R. M., Nalluri, S., Bachaboina, L., Rocconi, R. P., Athar, M., Owen, L. B., & Palle, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606483 · Cited by 42
Kim, N., & Song, K. (2013) · Cell Structure and Function · doi:10.1247/csf.12014 · Cited by 45
Fadlalla, K., Watson, A. M., Yehualaeshet, T., Turner, T., & Samuel, T. (2011) · PubMed · Cited by 41
Mortusewicz, O., Herr, P., & Helleday, T. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.20 · Cited by 41
“These DSBs lead to the activation of the ATM–p53 tumour barrier that prevents tumour growth, but can also drive genetic instability in cancer (Bartkova et al , 2006; Di Micco et al , 2006).”
Self-citationDNA damage, tumor mutational load and their impact on immune responses against cancer
Liontos, M., Anastasiou, I. P., Bamias, A., & Dimopoulos, M. A. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.07.11 · Cited by 44
“In addition, the deregulation of the replication process itself is another source of DNA alterations that may promote the carcinogenesis process (12).”
BackgroundSelf-citationPerturbations in the Replication Program Contribute to Genomic Instability in Cancer
Blumenfeld, B., Ben‐Zimra, M., & Simon, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061138 · Cited by 42
“H-RasV12 Oxidative stress, hyperreplication [55,58,60,61]”
BackgroundKondo, T. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.003 · Cited by 43
Iotti, G., Longobardi, E., Masella, S., Dardaei, L., Santis, F. D., Micali, N., & Blasi, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105216108 · Cited by 45
“The question, therefore, becomes whether Prep1 deficiency directly increases DNA damage or causes replication stress (41, 42).”
BackgroundXu, Q., Ma, P., Hu, C., Chen, L., Xue, L., Wang, Z., Liu, M., Zhu, H., Xu, N., & Lu, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041862 · Cited by 39
“Our knowledge of the relationship between cancer and senescence was greatly pushed forward as the discovery that overexpression certain oncogenes could induce premature senescence in vitro [41,42,43].”
BackgroundMasterson, J. C., & O’Dea, S. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32825209f6 · Cited by 46
Cyclin D1 Integrates Estrogen-Mediated DNA Damage Repair Signaling
Li, Z., Chen, K., Jiao, X., Wang, C., Willmarth, N. E., Casimiro, M. C., Li, W., Ju, X., Kim, S. H., Lisanti, M. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3137 · Cited by 43
Cholangiokines: undervalued modulators in the hepatic microenvironment
Cai, X., Tacke, F., Guillot, A., & Liu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192840 · Cited by 40
SnoN functions as a tumour suppressor by inducing premature senescence
Pan, D., Zhu, Q., & Luo, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.250 · Cited by 45
Hubáčková, S., Krejčíková, K., Bártek, J., & Hodný, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316869 · Cited by 46
“Notably, initial but not advanced tumor stages contain senescent cells (38), and there is evidence that all forms of cellular senescence are accompanied by production of IL6 (26, 32, 76–78, 83).”
BackgroundOncogene-Induced Replication Stress Drives Genome Instability and Tumorigenesis
Sarni, D., & Kerem, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071339 · Cited by 41
“This DDR activation could lead to proliferation arrest either in the form of senescence or apoptosis, forming a tumorigenic barrier [13,14].”
BackgroundLiedtke, K. R., Freund, E., Hermes, M., Oswald, S., Heidecke, C.-D., Partecke, L.-I., & Bekeschus, S. (2020) · Cancers · doi:10.3390/cancers12010123 · Cited by 42
p53 regulated senescence mechanism and role of its modulators in age-related disorders
Pawge, G., & Khatik, G. L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114651 · Cited by 44
Wang, J., Li, Z., & Willner, I. (2022) · Nature Communications · doi:10.1038/s41467-022-32148-9 · Cited by 41
Sherman, M. Y., Le, M., Stampfer, M. R., Gabai, V. L., & Yaglom, J. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00736.x · Cited by 41
“In fact, various oncogenes such as KRAS, BRAF, Mek, or Mos were shown to stimulate senescence both in fibroblasts and in transformed cell lines (Serrano et al., 1997; Lin et al., 1998; Zhu et al., 1998; Bartkova et al., 2006).”
BackgroundControversial aspects of oncogene-induced senescence
Bianchi-Smiraglia, A., & Nikiforov, M. A. (2012) · Cell Cycle · doi:10.4161/cc.22589 · Cited by 38
Mavrogonatou, E., & Kletsas, D. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21140 · Cited by 44
Self-citationSchepeler, T., Lamy, P., Hvidberg, V., Laurberg, J. R., Fristrup, N., Reinert, T., Bártková, J., Tropia, L., Bártek, J., Halazonetis, T. D., et al. (2012) · Oncogene · doi:10.1038/onc.2012.381 · Cited by 40
Self-citationHallmarks for senescence in carcinogenesis: novel signaling players
Caino, M. C., Meshki, J., & Kazanietz, M. G. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0316-z · Cited by 54
Marthandan, S., Menzel, U., Priebe, S., Groth, M., Guthke, R., Platzer, M., Hemmerich, P., Kaether, C., & Diekmann, S. (2016) · Biological Research · doi:10.1186/s40659-016-0095-2 · Cited by 39
Metabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39
HER2-mTOR signaling–driven breast cancer cells require ER-associated degradation to survive
Singh, N., Joshi, R., & Komurov, K. (2015) · Science Signaling · doi:10.1126/scisignal.aaa6922 · Cited by 39
Peng, S., Long, M., Chen, Q.-S., Yin, Z., Zeng, C., Zhang, W., Wen, Q., Zhang, X., Ke, W., & Wu, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02418-8 · Cited by 43
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
Functions of TopBP1 in preserving genome integrity during mitosis
Bagge, J., Oestergaard, V. H., & Lisby, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.08.009 · Cited by 40
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Theoretical considerations for thresholds in chemical carcinogenesis
Thomas, A. D., Fahrer, J., Johnson, G. E., & Kaina, B. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.05.001 · Cited by 44
DNA damage and cellular differentiation: More questions than responses
Simonatto, M., Latella, L., & Puri, P. L. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21275 · Cited by 39
“In support to the critical function of an accurate repairing system in proliferating cells, recent works have shown that accumulation of unrepaired lesions can eventually trigger senescence or malignant transformation (Kastan and Bartek, 2004; Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundPol η is required for DNA replication during nucleotide deprivation by hydroxyurea
de Feraudy, S. M., Limoli, C. L., Giedzinski, E., Karentz, D., Marti, T. M., Feeney, L., & Cleaver, J. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210385 · Cited by 45
“…damaged or replication is stalled, cells respond by activation of signal-transduction pathways that delay cell-cycle progression, induce repair of lesions, and trigger apoptosis or senescence to eliminate cells with potentially catastrophic mutations leading to malignancy (Bartkova et al., 2006).”
BackgroundWidespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia
Koorstra, J.-B. M., Hong, S., Shi, C., Meeker, A. K., Ryu, J. K., Offerhaus, G. J. A., Goggins, M., Hruban, R. H., & Maitra, A. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.114 · Cited by 44
The adenoma hunt in colorectal cancer screening: defining the target
Sillars-Hardebol, A. H., Carvalho, B. G., van Engeland, M., Fijneman, R. J. A., & Meijer, G. A. (2011) · The Journal of Pathology · doi:10.1002/path.3012 · Cited by 42
p35 Is Required for CDK5 Activation in Cellular Senescence
Mao, D., & Hinds, P. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066118 · Cited by 44
Myc, Cdk2 and cellular senescence: Old players, new game
Campaner, S., Doni, M., Verrecchia, A., Fagà, G., Bianchi, L., & Amati, B. B. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13049 · Cited by 44
Wang, H., Lee, A. Y., Chou, W., Wu, C., Tseng, C., Liu, K. Y.-T., Lin, W.-L., Chang, F., Chuang, D., Hunyadi, A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0921 · Cited by 45
“Conversely, ATR has been proposed to play a critical role in directing cell death by senescence in unperturbed cells, where ATR is activated by overexpression of the oncoprotein Mos or the ATR activator TopBP1, respectively (45, 46).”
BackgroundSahin, I. H., Iacobuzio-Donahue, C. A., & O’Reilly, E. M. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1094057 · Cited by 37
“However, there is also strong evidence that in the presence of intact tumor suppressor response, it may induce cellular senescence [13].”
BackgroundRimmelé, P., Komatsu, J., Hupé, P., Roulin, C., Barillot, E., Dutreix, M., Conseiller, E., Bensimon, A., Moreau-Gachelin, F., & Guillouf, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4691 · Cited by 38
“Spi-1 does not provoke DNA strand breaks but enhances genomic mutability Altered DNA replication leads to genomic instability in yeast (23) and human precancerous cells (2, 3, 5, 7).”
Background
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.